COMPANY SEARCH RESULT

Last update : 28/01/2011 >View issuer details
2021.01.11 | 22:30 | Permanent Information Releases / General Company News
Novartis expands Oncology pipeline with in-licensing of tislelizumab from BeiGene - HTML (w)
2020.12.18 | 22:50 | Permanent Information Releases / General Company News
Novartis receives complete response letter from U.S. FDA for inclisiran - HTML (w)
2020.12.16 | 01:17 | Permanent Information Releases / General Company News
2020.12.15 | 07:15 | Permanent Information Releases / Sales and Revenues
2020.12.14 | 07:15 | Permanent Information Releases / General Company News
2020.12.09 | 15:45 | Permanent Information Releases / General Company News
2020.12.09 | 15:00 | Permanent Information Releases / General Company News
2020.12.08 | 16:00 | Permanent Information Releases / General Company News
2020.12.05 | 16:00 | Permanent Information Releases / General Company News
2020.12.04 | 18:30 | Permanent Information Releases / General Company News
2020.11.24 | 07:00 | Permanent Information Releases / General Company News
2020.11.19 | 22:30 | Permanent Information Releases / General Company News
2020.11.19 | 15:43 | Permanent Information Releases / General Company News
2020.11.19 | 07:15 | Permanent Information Releases / General Company News
Novartis set to achieve 100% renewable electricity in its European operations - HTML (w)
2020.11.13 | 16:00 | Permanent Information Releases / General Company News
Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 1384